GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mendus AB (OSTO:IMMU) » Definitions » Short-Term Debt

Mendus AB (OSTO:IMMU) Short-Term Debt : kr0.00 Mil (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Mendus AB Short-Term Debt?

Mendus AB's Short-Term Debt for the quarter that ended in Sep. 2024 was kr0.00 Mil.

Mendus AB's annual Short-Term Debt increased from Dec. 2021 (kr0.00 Mil) to Dec. 2022 (kr29.20 Mil) but then declined from Dec. 2022 (kr29.20 Mil) to Dec. 2023 (kr0.00 Mil).


Mendus AB Short-Term Debt Historical Data

The historical data trend for Mendus AB's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mendus AB Short-Term Debt Chart

Mendus AB Annual Data
Trend Jun14 Jun15 Jun16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 14.88 - 29.20 -

Mendus AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Mendus AB Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Mendus AB Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Mendus AB's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Mendus AB Business Description

Traded in Other Exchanges
Address
Vastra Tradgardsgatan 15, Stockholm, SWE, 11153
Mendus AB is a clinical-level biopharmaceutical company based on the company's allogeneic dendritic cell biology focused on the development of immunotherapies that address tumor recurrence and hard-to-treat established tumors. Its operations consist of research and development for pharmaceuticals.

Mendus AB Headlines

From GuruFocus